Double-Blind, Randomized, Historical Control Study of the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects with Partial Epilepsy Not Well Controlled By Current Antiepileptic Drugs.
Summary
The Research Study is being conducted in order to evaluate the safety and efficacy of the experimental medication eslicarbazepine acetate in subjects with partial epilepsy not well controlled by their current medications.
How Can You Qualify?
The researchers at Princeton Medical Institute are seeking for males and females 16-70 years old with partial epilepsy. Other criteria for eligibility will be discussed with interested persons, without obligation, when calling the telephone number listed below. All study related visits, laboratory work, study medication, and all study related procedures including physical exams are provided at no cost. Qualified participants will receive compensation for time and travel.
Principal Investigator
Wayne Macfadden, MD
Contact
Benjamin Shechet, CRC
-
1-609-921-6050
Location
GMI Corporate/Princeton Medical Institute - Princeton, New Jersey
